Abstract
Background: Leaves of Ginkgo biloba, a “living fossil,” have been used as traditional herbal medicine for hundreds of years in China. Currently, its application in vascular protection is garnering much attention.
Methods: In this manuscript, preclinical studies were reviewed to discuss various mechanisms underlying the vascular protection by Ginkgo biloba extract (GBE). Additionally, we reviewed clinical studies to present the application of GBE in the ischaemic disease.
Results: GBE, a commonly used dietary supplement, has been shown to act as an antioxidant and freeradical scavenger, a membrane stabilizer, an inhibitor of the platelet-activating factor, a vasodilator, and a regulator of metabolism. Currently, there exist a growing number of clinical studies about GBE in the application of cardiovascular disease, peripheral vascular disease (PVD) and diabetic vascular complications.
Conclusion: GBE, a promising therapeutic agent for cardiovascular and ischaemic diseases, exerts vascular- protection function by a comprehensive mechanisms.
Keywords: Ginkgo biloba, Ginkgo biloba Extract (GBE), vascular protection, molecular mechanisms, cardiovascular disease, Chinese medicine.
Graphical Abstract
Current Vascular Pharmacology
Title:Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications
Volume: 15 Issue: 6
Author(s): Jinfan Tian, Yue Liu* Keji Chen
Affiliation:
- Cardiovascular Disease Centre, Xiyuan Hospital, China Academy of Chinese Medical Sciences, P.O. Box: 100091, Beijing,China
Keywords: Ginkgo biloba, Ginkgo biloba Extract (GBE), vascular protection, molecular mechanisms, cardiovascular disease, Chinese medicine.
Abstract: Background: Leaves of Ginkgo biloba, a “living fossil,” have been used as traditional herbal medicine for hundreds of years in China. Currently, its application in vascular protection is garnering much attention.
Methods: In this manuscript, preclinical studies were reviewed to discuss various mechanisms underlying the vascular protection by Ginkgo biloba extract (GBE). Additionally, we reviewed clinical studies to present the application of GBE in the ischaemic disease.
Results: GBE, a commonly used dietary supplement, has been shown to act as an antioxidant and freeradical scavenger, a membrane stabilizer, an inhibitor of the platelet-activating factor, a vasodilator, and a regulator of metabolism. Currently, there exist a growing number of clinical studies about GBE in the application of cardiovascular disease, peripheral vascular disease (PVD) and diabetic vascular complications.
Conclusion: GBE, a promising therapeutic agent for cardiovascular and ischaemic diseases, exerts vascular- protection function by a comprehensive mechanisms.
Export Options
About this article
Cite this article as:
Tian Jinfan , Liu Yue *, Chen Keji , Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications, Current Vascular Pharmacology 2017; 15 (6) . https://dx.doi.org/10.2174/1570161115666170713095545
DOI https://dx.doi.org/10.2174/1570161115666170713095545 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Atrial Fibrillation in Acute St-Elevation Myocardial Infarction: Clinical and Prognostic Features
Current Cardiology Reviews MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art
Current Medicinal Chemistry Aspirin: from a Historical Perspective
Recent Patents on Cardiovascular Drug Discovery Relation Between Obstructive Sleep Apnea Syndrome and Resistant Hypertension - The Tip of the Iceberg
Current Respiratory Medicine Reviews Circulating Levels of Uric Acid and Risk for Metabolic Syndrome
Current Diabetes Reviews Influence of Dietary Substances on Intestinal Drug Metabolism and Transport
Current Drug Metabolism Clinical Management of the Cardiovascular Failure in Sepsis
Current Vascular Pharmacology Role of Endogenous Androgen Against Insulin Resistance and Athero-sclerosis in Men with Type 2 Diabetes
Current Diabetes Reviews Atrial Fibrillation Recurrence: The Roles of Hypertension, Duration of Atrial Fibrillation Disease, and Prolonged Signal-Averaged P Wave Duration
Current Cardiology Reviews Chemistry and Biological Activities of Buxus Alkaloids
Current Bioactive Compounds Meet Our Editorial Board Member
Current Clinical Pharmacology Oxidative/Nitrosative Brain Damage in Stress: Possible Target for Neuropsychopharmacological Drugs
Current Medicinal Chemistry - Central Nervous System Agents Gene Expression Analysis Approach to Establish Possible Links Between Parkinson's Disease, Cancer and Cardiovascular Diseases
CNS & Neurological Disorders - Drug Targets microRNAs in Cardiovascular Disease: Small Molecules but Big Roles
Current Topics in Medicinal Chemistry Recent Advances in Pulmonary Hypertension Therapy
Recent Patents on Cardiovascular Drug Discovery The Antiplatelet and Antithrombotic Actions of Statins
Current Pharmaceutical Design Targeting Myocardial Metabolism for the Treatment of Stable Angina
Current Pharmaceutical Design Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry An Artificial Immune Network Based Algorithm for Diabetes Diagnosis
Protein & Peptide Letters Biomarkers in Lone Atrial Fibrillation-An Additional ‘Fine Tuning’ of Risk?
Current Pharmaceutical Design